Skip to content

Tag: ACIP

Published on Leave a comment on End of an Icon?

What happens when a prominent public figure who thinks he knows everything about everything finds himself in a position to control an important public institution? It's another brave new world we'll need to endure as best we can.

Of course I'm speaking about the Broccoli family ceding creative control of the iconic James Bond franchise to Amazon/MGM, i.e. Jeff Bezos. I shudder at the possibilities of another billionaire-induced stream of havoc.

Er, no. What I'm really referring to is the postponement of this week's meeting of CDC's Advisory Council on Immunization Practices. I had detailed last week that it was scheduled for February 26-28 as one of the three planned meetings this year; the dates are selected well in advance and had been planned through 2027. Not any more, apparently.

These meetings, with the entire public invited to view in real time, were among the most transparent of all healthcare meetings in our country. I'm not sure what public comment accommodations were needed; comments had been requested via the Federal Register as per standard practice, and the draft agenda already included the usual times for live public comments prior to all votes. The concern is that RFK, Jr., will overhaul committee membership to install new members to carry out his anti-science doctrine. The website promises that the ACIP workgroups will still present their findings, but I'm concerned the votes could look much different by the time that happens.

Coupled with potential new rules for FDA and research funding, we could end up with no progress in vaccine development and increasing vaccine hesitancy in the general public. At worst, we may lose access to currently available safe and effective vaccines. The ACIP could cease to be a reliable partner for our nation's health. Private organizations, including the American Academy of Family Physicians, the American Academy of Pediatrics, and the American College of Physicians, among others, may need to step forward to fill the vacuum of discussion and recommendations.

As I step down from my soap box, Ambrose Bierce reminds me, "Speak when you are angry and you will make the best speech you will ever regret.”

Good News Department

After my Debbie Downer impersonation above (did you watch SNL's 50th Anniversary show?), I'm thankful I saw more positives than negatives this past week.

MMWR is Back in Form

The February 20th issue looked a lot more like a typical edition. It had 4 topics and didn't appear to be skimping/censoring information. Of course the biggest news from an infectious diseases standpoint is the report of 2 exclusively indoor pet cats from 2 separate households in Michigan who died from avian flu. Owners of both cats were workers on dairy farms. The cats never had direct exposure to the farms.

The investigation was somewhat limited by incomplete testing. The most logical conclusion is that these 2 episodes represent passage of the virus from humans to cats.

Polio Vaccination Resumes in Gaza

WHO reports another round of polio vaccination is ongoing now in the Gaza strip after wastewater monitoring recently showed a poliovirus spike. Almost 600,000 children under 10 years of age have been identified to receive vaccination through February 26.

Low Dose Yellow Fever Vaccine Produces Similar Seroconversion Rates

At first glance, this might not seem that important to those outside of the yellow fever world. However, yellow fever vaccine is in short supply at a time when this hemorrhagic fever virus is surging in many parts of the world, including the Americas. Investigators published a non-inferiority randomized, double-blind controlled trial of standard dose (13,803 IU) compared to lower doses of 1000, 500, or 250 U administered to adults in Uganda and Kenya.

Using a lower vaccine dose vastly increases the number of people residing in high-risk countries who can be vaccinated. Note that in addition to 29 African countries, 13 countries in Central and South America have some risk of yellow fever transmission.

Listeria Outbreak Linked to Frozen Shakes

Mostly these nutritional supplements are used in long-term care facilities. I haven't noticed any of these products in my local grocery stores. Last Friday FDA reported on the outbreak that first came to light in November 2024 and covers 21 states across the country. Thirty-eight individuals have been infected, resulting in 37 hospitalizations and 11 deaths. The high morbidity and mortality probably relate to the high-risk populations residing in these facilities. If you visit one a nursing home it's worth a mention to the staff to make sure they are aware.

Measles

I'm afraid that reports of vaccine-preventable diseases will increase in the current regulatory and cultural climate. Friday's update from Texas Health and Human Services now lists the total number at a whopping 90 cases, and if news reports are to be believed this is significantly under-reported due to high rates of home schooled children affected. Added to this are 9 cases just across the border in New Mexico, though news reports state there is no known contact to infected individuals in Texas. That seems to be a very unlikely coincidence.

Last week I mentioned that I thought the CDC needed to update their measles tracking page more frequently than monthly, and they listened to me! Now we have updates every Friday.

We haven't broken any records yet, here's hoping Texas officials get this under control soon.

WRIS

It's nice to see the influenza-like illness curve head down this past week, but it could bounce up again like it's done before.

Hospitalizations for confirmed influenza infections also trended down.

Mortality is the highest we've seen since the pandemic. The numbers below include 86 pediatric deaths.

On a national level, covid and RSV aren't doing much, though even low levels result in significant disease.

Bernarr Macfadden

Yeah, I never heard of him either, but opinion columnist Jessica Grose at the NY Times brought him to my attention as a precursor/dopelganger for RFK, Jr. Unfortunately Macfadden's Wikipedia article has too many poorly documented statements to recommend, but what I can verify is that he was a weight-lifter who liked to be photographed showing his muscles (and most of his body) and founded various health movements. A charismatic individual, his influence was prominent from the early 1900s through World War II. He had no medical background. He championed raw milk and denounced white bread and pharmaceutical agents including vaccines. His "movement" reportedly had prominent adherents including Franklin Roosevelt and Rudolph Valentino. Eerily familiar.

As a distraction, I found myself wondering how Jeff Bezos would tilt his newfound power to influence the future of James Bond. I know just the person to play the next villain.

Courtesy of YouTube

Published on Leave a comment on The Kennedy Era

Readers of past postings know I try to avoid politics in this blog. Today's post represents a complete failure to achieve that goal. I have followed RFK Jr.'s statements and writings about vaccines and public health for many years. His brand of pseudo-science is incomprehensible to me and anyone who understands biology and scientific methodology. His confirmation as HHS Secretary last week marks a sea change in the American health system; although he spouts some worthwhile targets to improve public health, in his new position he poses a grave public health threat for infectious diseases in particular. Regardless of any specific vaccine or other policies he might introduce, his mere confirmation as HHS Secretary may serve to further normalize anti-vax sentiment and likely will increase rates of vaccine refusal. Welcome to the new Dark Ages, though I doubt it will last several centuries like the last one. More on this later.

The Global Watch

A number of things to be aware of globally, though none immediately troublesome for the US.

Marburg Outbreak in Tanzania

This outbreak of a viral hemorrhagic fever disease (similar to Ebola) was declared about a month ago. Ten cases (2 confirmed, 8 suspected) have been identified, all fatal. Now, the 281 contacts of those 10 cases have passed the 21-day incubation period and remain well, very reassuring. However, WHO still rates the risk at the national level as high, given that the locale, Kangera, is a major regional transportation hub to other countries. Risk for global spread is still low.

Ebola (Sudan virus) Outbreak in Uganda

AfricaCDC reports that the vaccine trial is underway now in 7 of the 8 planned sites. Disease activity seems relatively stable, though the weekly reports tend to lag with last update posted from February 10.

PPE for VHF

With every viral hemorrhagic fever outbreak, healthcare providers comprise a prominent number of infected individuals. This occurred even in the US when 2 American nurse providers were infected during the 2014 importation from travelers. It's a good time to remember precautions to prevent VHF spread in healthcare settings, also a bit confusing since different guidelines apply according to whether the suspected patient is clinically stable or unstable. Front line providers need to contact their friendly local ID or infection control practitioner for help as soon as a suspected VHF case is encountered. Remember to obtain a good travel history.

mpox

In WHO's February 13 situation report, clade Ib mpox remains primarily in the DRC, Rwanda, and Uganda. MMWR just reported confirmation of a case of Ib infection in California from November 2024, in a traveler returning from east Africa. More on MMWR later.

Measles Again!

No surprise, but we have new outbreaks in the US, presumptively heavily related to cases in unvaccinated persons who were old enough to have received 2 doses of MMR vaccine.

A February 14 update from the Texas Department of State Health Services lists a total of 48 cases in the South Plains region, with age distribution of 13 cases in 0-4 year-olds, 29 in school-aged children (5-17 yo), 5 18 and older, and 1 with age unknown. Digging through the data from their spreadsheet links, MMR coverage in 2023-24 in the Seminole ISD (apparently the epicenter of the outbreak) is an appallingly low 82%. In Gaines County, home of 42 of the outbreak cases, the rate of "Conscientious Exemptions" for vaccine administration for children rose from 7.45% in 2013-14 to 17.62% in 2023-24. Even the earlier rate is super-high. Gaines County is the red box below.

The CDC measles page is updated only monthly, perhaps not frequently enough given the current situation. And, speaking of the CDC ...

Interesting Week Ahead for the CDC

I'll be watching closely this week. MMWR seems to be back, but with fewer topics per issue. I looked at the 2024 content, and only about 10% of the weekly publications had less than 4 topics. Both issues following the "publication pause" had only 2 articles each.

More telling, the Advisory Council on Immunization Practices is scheduled to meet on February 26-28. The draft agenda was released on January 19, and I'll be interested to see if the topics change. Currently on the schedule are votes on meningococcal, chikungunya, and influenza vaccines plus further discussion on maternal and pediatric RSV vaccines on Wednesday. These are not particularly high profile targets for the anti-vaccination lobby or for anti-DEI issues. However, part of the discussion process for vaccines at ACIP meetings has been an "Evidence to Recommendations" portion that normally includes a section on equity. I wonder whether this will change. Thursday's draft agenda includes perhaps more controversial subjects of HPV and mpox vaccines, due the relationship of these infections to spread via sexual contact in different high risk groups. Thursday's discussion also touches on pneumococcal and adult RSV vaccines, plus a 5-minute blurb on Lyme disease vaccination that I'm wondering about. The meeting wraps up Friday morning with discussions on covid (!) and CMV vaccines. I hope to attend much of the meetings and I'll report back next week.

This week's New England Journal of Medicine included a Perspective written by 3 former editors-in-chief of MMWR plus a former director for one of CDC's Centers. It was entitled "The Consequences of Silencing the 'Voice of CDC.'" Clearly the authors carry some implicit bias in favor of the CDC, but the article was enlightening. They repeated the reports I heard that the February 6 issue suppressed a discussion on H5N1 influenza (may have related to spread between cats and humans), which is concerning. I was interested to learn a bit of history: MMWR first appeared in 1961, during my lifetime but in a period when my interests fell more along the lines of Tinkertoys and butterflies. Currently I am one of 147,000 electronic subscribers to MMWR. CDC shares titles and brief summaries of reports with the Office of the Assistant Secretary for Public Affairs at HHS to alert them of content, but the authors were not aware of any time the reports had been altered or censored by the executive branch.

The authors went on to mention how rapid publication in MMWR helped public health management, citing the initial descriptions of what was eventually AIDS, outbreaks of foodborne illness related to hamburger contaminated with E. coli O157:H7, and anthrax related to intentional distribution of anthrax spores. I was a practicing pediatric ID physician during all of these outbreaks and still remember reading MMWR and changing my practice to account for new disease situations.

In addition to the evolving VHF situation in Africa mentioned previously, we need ongoing high-level surveillance for avian flu and for the large outbreak of tuberculosis in Kansas. With regard to the former, we did hear some information in MMWR this week: new serologic evidence of H5N1 infection in veterinarians providing care for cattle but with no known link to infected herds, suggesting more widespread cow infection than has been detected so far.

As an aside, since I do most of the grocery shopping in my household, I discovered the USDA has egg market reports. If you need some distraction from hand-wringing, you can track how many 30-dozen egg cases are moving around in your region each weekday!

WRIS

I'm thinking I don't need to tell any front line healthcare provider that influenza season is in full swing and is the one prominent player in our winter respiratory infection season at the moment.

More concerning is that illness severity is quite high.

Virtually all circulating strains are influenza A, and avian flu is not contributing to this with still just a handful of human cases detected in the US. Not too late to vaccinate.

My Test Grade Was 3

Please pardon my error last week in inviting readers to take the "How Ignorant Am I?" online quiz, not realizing it required subscription access. The quiz itself is based on a 1950 publication by statistician and weather forecaster Glenn W. Brier, updated in the Nature article you probably can't access. Briefly, the new quiz consists of 5 questions covering percentage of water in human body parts, timing of publication of genetic theories, planet size, number of atoms in common molecules, and melting points of precious metals; in short, scientifically based but nothing recently discovered. The kicker to the quiz is that it's not just whether you provide the correct answer, but that you quantify your confidence in the answer you provided. The scoring system is weighted such that failure (getting the wrong answer but thinking you are correct) is punished more severely than rewarding success (just getting the right answer). Here's the scoring interpretation: "If you ended up with a negative total, you did worse than a complete ignoramus who just answered 5 to every question" [5 indicates you had no idea which answer was correct, resulting in a score of zero if you answered 5 for all questions]. "People who actually know a lot, or are extremely lucky, get higher scores." (The highest possible score, getting all answers correct and being absolute certain of your answers, is 125.). So, my score of 3 isn't great, with a consolation prize that "Those with an awareness of their own doubts ... might end up with a small positive score." The main point of the quiz was " ... to train forecasters to be less over-confident, and have insight into their own thought processes." Applies to weather forecasters and possibly to healthcare providers as well!

Published on Leave a comment on Autumn Has Broken ….

Leaves are everywhere, including still attached to trees and waiting to further increase my workload. I'm starting to plan my leaf management strategy; when to clear the gutters, waiting for the county to post its leaf collection dates, reflecting on my love/hate relationship with my garden rakes.

... But Still Waiting on WRIS

Covid is as quiescent as it ever gets, flu and RSV still low but hints of increase. I'll enjoy it while I can. As always, CDC has resources to look specifically at activity in your region.

Potpourri

In spite of the relative calm in infectious diseases, I found plenty of tidbits last week. I'll start with some good news.

WHO Declares Egypt Malaria-Free

The news release commented that this is the culmination of 100 years worth of effort. Forty-four countries and one territory have achieved this certification worldwide, which requires demonstration that malaria transmission from local Anopheles mosquitoes has been stopped for 3 consecutive years. In the WHO Eastern Mediterranean region, only 2 other countries, UAE and Morocco, have achieved this landmark. Given that some of our earliest evidence of malaria in humans comes from studies of ancient Egyptian mummies, it's pretty amazing to see a 6-thousand-plus year trend ended.

Mpox Age Distribution

A recent study from Burundi highlights a trend in recent mpox cases in the region, now seeming to cluster in children disproportionately. Here's the breakdown:

The authors state they could not identify reasons for this unusual age distribution, and I expect we'll hear more about that. They also noted that cases were more severe in individuals 15 years of age and older.

Community Acquired Pneumonia Due to Avian Chlamydia abortus in the Netherlands

One more cause of zoonotic pneumonia to add to our lists, based on this new report. Dutch investigators provide a convincing story for an infection cluster in 1 family, including 1 person with severe pneumonia, occurring in late 2022. This novel avian strain was first reported in 2021, and I suspect we'll be seeing more reports of this organism now with perhaps evidence that human infections have been occurring for some time. I'm especially anxious to hear more about the spectrum of clinical disease, hoping that this is mostly a mild pneumonia.

Iquitos Virus

Just as I was starting to get a feel for Oropouche virus (OROV) disease, now I need to learn about a close cousin (IQTV) that was found to cause infection in a traveler returning from Ecuador. Under the category of more than I needed to know, these viruses are part of the Simbu group of about 20 bunyaviruses including the amazingly named Madre de Dios virus. The traveler in the case report returned after a 10-day trip to Ecuador where he experienced many insect bites and presented with fever, chills, sweats, headache, pain with eye movement, and rash. He was thought to have OROV infection, but he fortuitously presented for care in Atlanta where his samples landed at the CDC and further testing revealed the true culprit to be IQTV. The traveler did not require hospitalization and recovered uneventfully.

Hold the Onions

The only way to have avoided hearing about this month's E. coli O157:H7 outbreak linked to Big Macs is to be completely cut off from all news and social media sources. It is centered in Colorado but also present in several neighboring and nearby states. As of the latest update on October 25, the case total is 75 with 22 hospitalizations and 1 death spread over 13 states.

CDC hasn't yet provided any detail about range of symptoms in this outbreak, but presumably the more severe cases represent instances of hemolytic-uremic syndrome. Although O157:H7 and HUS is classically associated with contaminated ground meat, that source didn't seem to make sense in this outbreak. All of these fast food chains have automated cooking methods that would reliably kill bacterial pathogens; it is conceivable the equipment could break down in one restaurant, but not particularly plausible for so many sites occurring at once. The hunt changed to uncooked foods with raw onions now the presumptive culprit.

These circumstances reminded me of a child with no travel history that I diagnosed with typhoid fever decades ago. It was eventually traced to the shrimp salad at a local McDonald's restaurant, prepared by a modern-day Typhoid Mary.

ACIP Meeting

I'd be totally remiss if I didn't mention the regular meeting of CDC's Advisory Council on Immunization Practices last week. However, most of the newsworthy items concerned adult vaccinations (e.g. lowering the recommended age for pneumococcal vaccines). They did approve the 2025 child and adult immunization schedules The final version is not yet available, but you can look at the drafts. Note that a second dose of covid vaccine will be recommended for immunocompromised and high risk children adults 6 months after the fall vaccination. Also see ongoing tweaks to the meningococcal vaccine recommendations appearing on slide 27.

While we wait for official pronouncements, you can find a summary of all the meeting recommendations here.

Published on Leave a comment on Meh

I had expected last week's ACIP meeting to include more presentations and discussions about which covid strain to include in our fall vaccine. I viewed only a small portion of the meeting live (darn those pesky patient care issues!), so I probably missed any brief mention of strains; the slides themselves didn't address strain selection, other than to go with the FDA's statement for use of JN.1 lineage with preference for KP.2 if possible. I still found some interesting details about covid and nirsevimab and will share those with you. Perhaps meh is a bit of a harsh judgement, but I love the word.

In the meantime, thankfully still not much going on in the pediatric infectious diseases world this summer.

Love That New Technology

The CRISPR technology has been in the news for a long time. In case you had forgotten, like I did, it stands for Clustered Regularly Interspaced Short Palindromic Repeats and is now reported to have high sensitivity and specificity for detecting antiviral drug resistance and influenza subtype rapidly enough to be used as a point-of-need assay. The study itself requires journal subscription (thank you, GWU faculty status) to read in full. Investigators studied influenza isolates from the 2020-21 season looking primarily at AH1N1 and AH3N2 strains. The report is highly technical, beyond my ability to critique the laboratory methods, but the take-home message is important: if such a method is scalable (e.g. cheap enough) to employ across the world, including in resource-poor communities, it would be a boon to early warnings of resistant and/or new flu strains. I'm keeping my fingers crossed.

I must applaud scientists in this realm for their acronym constructions: in addition to CRISPR and others, they also used DETECTR (DNA endonuclease-targeted CRISPR trans reporter) and SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing) assays. Elementary, my dear Watson. (And, that phrase never appeared in any of Arthur Conan Doyle's writings!)

Dengue HAN

Perfect timing after my mention of dengue last week, the CDC issued a Health Alert Network warning about dengue in the US. According to the Pan American Health Organization, early signs are that cases in the Americas this year will exceed last year's numbers, a year that was already much higher than previous years. Here's an example from the report of what's going on in the Caribbean subregion:

Puerto Rico is under a healthcare emergency because of dengue, and we will certainly have cases of autochthonous (acquired in the US without travel to an endemic area) transmission in the mainland US again this year, primarily in Florida and other southern states. The HAN is worth reading.

This would be a good time to review clinical presentations of dengue and be prepared to investigate/obtain consultation for suspected cases.

Pustules and Vesicles in Afebrile Infants <60 Days of Age

Pediatrics had a nice retrospective review of 183 infants from 6 academic hospital-based pediatric dermatology practices. It's open access and has a nice suggested management algorithm.

Note the first branch in the algorithm details key features to decide whether HSV evaluation and treatment is recommended.

ACIP Meeting Highlights

The regular meeting was spread over 3 days last week. Slides are posted, and I picked out a few that contained interesting new information.

First, even with all the problems of supply chain and late administration, nirsevimab appears to have been incredibly effective in preventing RSV hospitalizations and healthcare visits.

Yes, that's about 98% effectiveness in preventing hospitalization, with very narrow confidence intervals. When this slide was shown it elicited a round of applause from the committee members. This is truly remarkable. Similar results were seen using a different RSV surveillance method. Both the above and below slides are from the Payne presentation on June 28.

It appears we'll have better availability of nirsevimab for the next RSV season, so please prepare for that. I find myself fantasizing of some future day when new pediatric trainees won't see hordes of infants hospitalized with RSV bronchiolitis, with worried parents at the bedside.

Second, although I mentioned I didn't see any new data/discussion about strain selection, the covid vaccine discussion had useful updates about epidemiology and risk factors, mainly from the Haver presentation on June 27.

About half of children hospitalized for covid had no underlying risk factors; we already knew that, but here's a more detailed breakdown. Note that these numbers are for the past year, at time when virtually all US children had some prior antibody from infection and/or vaccine.

Here is the vaccination status, including the low numbers who received the 2023-24 version, of the hospitalized children:

One BIG disappointment for me with the presentations: there was no mention of a control group - i.e. what are the rates of underlying medical conditions and 2023-24 vaccine status in the pediatric population as a whole? Adjusting for rates in the general population would provide a better estimate of the relative contributions of risk factors and vaccination to more serious outcomes and give us a better handle on the magnitude of benefit of vaccination, for example. Still, nothing has changed; for the individual child, covid vaccination is better than not being vaccinated, even factoring in the low rates of serious outcomes and adverse vaccine events in children.

The 2023-24 vaccine was highly effective against emergency department and urgent care visits in all age groups, though waning of protection over time was seen. Lack of enough events of hospitalized children precluded reliable estimates of VE against pediatric hospitalizations. (Link-Gelles presentation June 27.)

Bird Flu

Exciting (to me) news that CDC is collaborating with the Michigan health officials to carry out a seroprevalence study for H5N1 infection in Michigan dairy workers. This should produce much better information about asymptomatic and mild infection in humans and possibly lead to more clues about transmission.

Covid Uptick?

Still a question, but positive test percentages are increasing, albeit at a low level and predominantly driven by western states.

Wastewater variant detection is lacking across the country, see all the block dots (no sequencing data) below, but you can magnify your area of the country and find a few sites with enough data to determine predominant covid strain.

For example, in my neck of the woods most of the sites have no sequencing data. Of the 2 that did, one showed a predominance of KP.2 and the other LB.1. Nationally, KP.3 is starting to exceed KP.2. Again, we're still at low numbers.

A Tip of the Hat to "The Simpsons."

I knew that "meh" might have been adopted from a Yiddish term meaning so-so or unimpressive, but it looks like a 1994 episode of the TV series The Simpsons, featuring ultraconservative Sideshow Bob, popularized the term. Lisa Simpson was investigating voter fraud as the reason Sideshow Bob was elected as Springfield's mayor, and the "meh" word was uttered by a Hall of Records bureaucrat when Lisa expressed disbelief that he would give her the entire mayoral voting records that should have been kept secret. (Thie episode is available only with subscription, but I verified the quote at about 15:30 time in the recording.)

Voter fraud 30 years ago?

Published on Leave a comment on No Spoilers From Me

It's my usual Sunday to put the final touches on this week's post though working on it earlier than my usual late morning start since I had to watch the Women's World Cup soccer match. In case you recorded it to watch later, I won't reveal any spoilers.

It's Official for Nirsevimab

On August 3 the ACIP voted to recommend the long-acting monoclonal antibody nirsevimab (brand name Beyfortus) to prevent RSV. It is recommended for use in all infants under 8 months of age, just before or during the RSV season, and also for infants 8-19 months of age with the usual high-risk medical conditions just before their second RSV season. Dr. Mandy Cohen, the new CDC director, formally adopted those recommendations. It will eventually replace the current product, palivizumab (Synagis), which has been administered just to the high-risk groups monthly during RSV season.

I didn't log in to the ACIP meeting but did review the slides and reports (available here). Most of the information had already seen the light of day at the prior FDA meeting that approved the product, but a few items are noteworthy.

First, authorities now refer to this product as a vaccine, although that's not quite true in the scientific sense. This is a strategy to try to have this funded by the Vaccines for Children program. The product will be very expensive (probably around $450 - 500 for a dose), and even standard health insurance companies are notorious in avoiding reimbursement for new products.

For infants born just before or during RSV season, nirsevimab would best be administered by the birthing hospital prior to discharge. I was surprised to learn that only 10% of US birthing hospitals participate in the VFC program. Most provide bundled services for deliveries; hepatitis B vaccine is often covered in this manner, but that cost is only $13-16 per dose. Will bundling work for a much more expensive product? These payment issues could impact ability to administer the new therapy particularly for the upcoming RSV season. There isn't much time to figure out these details.

Presentations from CDC personnel helped show the potential impact of nirsevimab, using a Number Needed to Immunize (again with the vaccine nomenclature). Based on the available 2 randomized controlled trials in mostly healthy infants, where ICU admissions were rare and deaths thankfully absent in the study infants, NNI was favorable particularly for preventing hospitalization but also for prevention of medically-attended illness.

In other words, 128 infants would need to receive nirsevimab to prevent 1 additional child from being hospitalized for RSV. Various cost-effectiveness analyses showed this to be a good use of funds.

Data are not yet available to perform similar analyses for high-risk infants receiving therapy prior to their second RSV season, but antibody levels in those infants following treatment strongly suggest it will be effective.

CDC will provide us with more detailed recommendations soon. They did provide an example of timing for "vaccination" with nirsevimab. As mentioned above, for children born just before or during RSV season (October 1 through March 31 in most parts of the US), nirsevimab would be administered at birth. Otherwise, administration would be timed for the well-child checks in primary care provider offices, perhaps in October and November. The October batch could include infants born the previous April (at their 6-month visit), June (4-month visit), and August (2-month visit). Infants born the previous May (6-month visit), July (4-month visit), and September (2-month visit) would receive their dose in November. A bit complicated, but at the moment I can't think of a better plan to make this run smoothly for office practices.

We also need guidance if FDA approves the maternal RSV vaccine for pregnant people. Providing nirsevimab to infants whose mothers were vaccinated during pregnancy is probably unnecessary. FDA is supposed to decide this month on the maternal RSV vaccine once they receive updated results from the ongoing trials.

Regardless, all pediatric healthcare providers need to stay tuned; this could be a major change in office practice this fall.

Don't Go Home With the Armadillo, etc.

A case report of possble authochthonous leprosy in central Florida reminds us that, Jerry Jeff Walker notwithstanding, one can acquire leprosy in the US without having contact with humans or armadillos with leprosy. The report and other epidemiologic evidence suggests that leprosy may be endemic in southeastern US.

Cold air might aid in croup treatment according to a new randomized controlled trial in an emergency department. In addition to treatment with dexamethasone, children with croup were randomized (not in a blinded fashion, obviously) to outside cold air for 30 minutes, compared to room temperature indoors. The cold air kids seemed to improve faster.

Conflict in My Favorite Medical Feed

I've been reading ProMED posts several times a day for years and have donated funds to them during that time. They were the first to report all 3 coronavirus outbreaks this century. I was a bit disappointed to learn recently that they will start charging a subscription fee but was resigned to the fact that I'd be shelling out a few more bucks. Now I've learned there's a big kerfuffle in the background. The frontline folks who do all the work are protesting new management moves. I hope this is resolved, I can't imagine life without ProMED.

'Demic Doldrums

No big changes this week, CDC numbers are similar to last week and all indicators point to an increase in SARS-CoV-2 activity in the US and elsewhere. Not to rely too much on anecdotal data, but my own primary care provider remarked to me at a visit last week that he has seen an upswing in positive tests in his practice. Let's hope this will be a minor blip and not the start of a large new wave.

Some Good News From Down Under

Again, no soccer spoilers from me. But, maybe flu has peaked in Australia; if so, this season is a bit better than 2022 and might bode well for our own flu season.

Unless otherwise indicated, the content and opinions expressed on this web site are those of the author(s). They are not endorsed by and do not necessarily reflect the views of the George Washington University.
Viewing Message: 1 of 1.
 Notice

This site uses cookies to offer you a better browsing experience. Visit GW’s Website Privacy Notice to learn more about how GW uses cookies.